Myelofibrosis (MF) Video Channel
Explore the latest insights and summaries from experts in Myelofibrosis (MF).
Recommended for You
Loading...
Trending Videos This Week
Loading...
Treatment Landscape
Vanderbilt University Medical Center (VUMC)
Management of MF After Ruxolitinib Failure
FEATURING
Ashwin Kishtagari
- 195 views
- July 18, 2024
- 2
Insights from 2024 EHA Annual Meeting
Top 5 Impactful MPN Abstracts From Summer Conferences
FEATURING
Prithviraj Bose
- 160 views
- July 31, 2024
MyCancerHaven
Experts Discuss Their Current Approach to Treating MF
FEATURING
Ravi Vij,
Abdulraheem Yacoub
- 125 views
- August 30, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in Heme Malignancies
FEATURING
Maria Gomes da Silva
- 468 views
- September 23, 2024
- 2
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current and Future Treatment Landscape of Myelofibrosis
FEATURING
Rami Komrokji
- 164 views
- October 8, 2024
- 1
Cleveland Clinic Taussig Cancer Institute
Updates in MPNs From ASH 2023
FEATURING
Rebecca B. Klisovic
- 10 views
- October 22, 2024
Indy Hematology Review
2024 Updates on Myelofibrosis and Systemic Mastocytosis
FEATURING
Raajit Rampal
- 332 views
- April 16, 2024
- 1
University of Colorado Division of Hematology
2024 Updates in MF
FEATURING
Brandon McMahon
- 76 views
- April 19, 2024
- 1
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for Myeloproliferative Neoplasms
FEATURING
Ayalew Tefferi
- 1,499 views
- April 23, 2024
- 10
Memorial Sloan Kettering Cancer Center
Key Updates in AML, MDS, & MF From ASH
FEATURING
Aaron Goldberg
- 303 views
- May 2, 2024
- 4
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
FEATURING
Ayalew Tefferi
- 1,345 views
- May 3, 2024
- 13
Winship Cancer Institute - Emory University
Updates on Myeloproliferative Neoplasms Including CML
FEATURING
Anthony Hunter
- 139 views
- May 7, 2024
Moffitt Cancer Center
Current Treatment Landscape of JAK Inhibitors in MF
FEATURING
Andrew Kuykendall
- 237 views
- May 13, 2024
Yale Cancer Center
Emerging Therapies in MF & PV: Insights From Recent Clinical Trials
FEATURING
Jan Bewersdorf
- 166 views
- May 14, 2024
- 1
GRACE
Approach to Selecting Treatment for Myelofibrosis in 2024
FEATURING
Andrew Srisuwananukorn
- 42 views
- November 25, 2024
MyCancerHaven
Experts Discuss How They Choose 2L Therapy in MF
FEATURING
Ravi Vij,
Prithviraj Bose
- 163 views
- August 30, 2024
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
2024 Updates in Myeloproliferative Neoplasms
FEATURING
Elizabeth Hexner
- 312 views
- March 3, 2024
- 1
UChicago Medicine
Overview of Recent Updates in MPNs and MDS
FEATURING
Satyajit Kosuri
- 285 views
- March 20, 2024
- 3
Incyte
Optimizing the Management of Patients with Polycythemia Vera (PV)
FEATURING
Prithviraj Bose,
Raajit Rampal
- 196 views
- October 10, 2024
- 1
The University of Kansas Cancer Center
Prioritizing Overall Survival in MF: Longterm Updates From COMFORT-I and II Studies
FEATURING
Abdulraheem Yacoub
- 19 views
- December 16, 2024
2024 ASH Annual Meeting Insights Hub
ASH 2024 Summary: Pegylated Interferon in MPN - The Who, Why, and How
FEATURING
Jean-Jacques Kiladjian
- 75 views
- December 17, 2024
- 3
Therapeutic Agents
Incyte
Effects of a Treatment Option on Hematocrit Control and Spleen Volume Reduction in Patients with PV
FEATURING
Claire Harrison
- 442 views
- July 1, 2024
- 1
Incyte
Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk
FEATURING
Claire Harrison
- 589 views
- July 1, 2024
Vanderbilt University Medical Center (VUMC)
Management of MF After Ruxolitinib Failure
FEATURING
Ashwin Kishtagari
- 195 views
- July 18, 2024
- 2
MyCancerHaven
Experts Discuss Their Current Approach to Treating MF
FEATURING
Ravi Vij,
Abdulraheem Yacoub
- 125 views
- August 30, 2024
Incyte
Importance of Early Management of Patients with Myelofibrosis (MF)
FEATURING
Prithviraj Bose,
Raajit Rampal
- 245 views
- October 10, 2024
- 2
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current and Future Treatment Landscape of Myelofibrosis
FEATURING
Rami Komrokji
- 164 views
- October 8, 2024
- 1
Yale Cancer Center
Myeloid Malignancies: Hot Topics in 2024
FEATURING
Nikolai Podoltsev
- 281 views
- October 21, 2024
Cleveland Clinic Taussig Cancer Institute
Updates in MPNs From ASH 2023
FEATURING
Rebecca B. Klisovic
- 10 views
- October 22, 2024
Alexander Coltoff
Survival as a Primary Goal in MF: Evaluating 5-Yr Data From COMFORT-1
- 81 views
- November 5, 2024
Indy Hematology Review
2024 Updates on Myelofibrosis and Systemic Mastocytosis
FEATURING
Raajit Rampal
- 332 views
- April 16, 2024
- 1
University of Colorado Division of Hematology
2024 Updates in MF
FEATURING
Brandon McMahon
- 76 views
- April 19, 2024
- 1
Prithviraj Bose
MANIFEST-2 Study: Pelabresib With Ruxolitinib for JAKi-Naïve Patients With Myelofibrosis
- 221 views
- April 22, 2024
- 1
Mary Frances McMullin
Quality of Life in Myelofibrosis Patients Treated With Momelotinib
- 211 views
- April 26, 2024
Memorial Sloan Kettering Cancer Center
Key Updates in AML, MDS, & MF From ASH
FEATURING
Aaron Goldberg
- 303 views
- May 2, 2024
- 4
Moffitt Cancer Center
Current Treatment Landscape of JAK Inhibitors in MF
FEATURING
Andrew Kuykendall
- 237 views
- May 13, 2024
Yale Cancer Center
Emerging Therapies in MF & PV: Insights From Recent Clinical Trials
FEATURING
Jan Bewersdorf
- 166 views
- May 14, 2024
- 1
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: MPN
FEATURING
John Mascarenhas
- 253 views
- March 22, 2024
Icahn School of Medicine at Mount Sinai
Stem Cell Pathways, Aging, and Cancer Evolution in MPN
FEATURING
Catriona Jamieson
- 20 views
- July 2, 2024
Icahn School of Medicine at Mount Sinai
Strategies to Overcome Immune Dysregulation in MPNs
FEATURING
Cansu Cimen Bozkus
- 30 views
- July 2, 2024
16th International Congress on Myeloproliferative Neoplasms
Clinical and Therapeutic Aspects of Chronic Inflammation in the MPNs
FEATURING
Hans Hasselbalch
- 44 views
- November 26, 2024
- 1
16th International Congress on Myeloproliferative Neoplasms
Selection of JAK1/2 Inhibitors for Primary Myelofibrosis
FEATURING
Aaron Gerds
- 78 views
- December 3, 2024
16th International Congress on Myeloproliferative Neoplasms
Novel Agents for MPNs in 2024
FEATURING
Naveen Pemmaraju
- 90 views
- December 3, 2024
- 1
Diagnostics & Biomarkers
University of Colorado Division of Hematology
2024 Updates in MF
FEATURING
Brandon McMahon
- 76 views
- April 19, 2024
- 1
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for Myeloproliferative Neoplasms
FEATURING
Ayalew Tefferi
- 1,499 views
- April 23, 2024
- 10
16th International Congress on Myeloproliferative Neoplasms
Allele Burden in MPN: Practical Considerations
FEATURING
Raajit Rampal
- 129 views
- November 26, 2024
- 1
16th International Congress on Myeloproliferative Neoplasms
The Importance of Chromosomes in MPN in 2024
FEATURING
Vesna Najfeld
- 15 views
- December 4, 2024
Disease Overview
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Retrospective Analysis of Primary MF Patients in Azerbaijan
FEATURING
Elmir Guluyev
- 11 views
- September 16, 2024
16th International Congress on Myeloproliferative Neoplasms
Polycythemia Vera Progression: Prevention and Prediction
FEATURING
Ghaith Abu-Zeinah
- 9 views
- December 4, 2024
16th International Congress on Myeloproliferative Neoplasms
MPNs in Children, Adolescents, and Young Adults
FEATURING
Nicole Kucine
- 19 views
- December 5, 2024
Case Studies
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Myelofibrosis Case Discussion: Patient With Splanchnic Venous Thrombosis
FEATURING
Weronika Lebowa
- 14 views
- September 25, 2024
Icahn School of Medicine at Mount Sinai
Targeting Mutant Calreticulin in MPN
FEATURING
Ann Mullally
- 47 views
- July 2, 2024
- 1
16th International Congress on Myeloproliferative Neoplasms
Predictors of Allogeneic Transplantation Outcome in Primary Myelofibrosis
FEATURING
Koen van Besien
- 43 views
- November 26, 2024